Antibodies for and treatment to prevent or reduce the severity of xenograft rejection

摘要

PCT No. PCT/US93/01743 Sec. 371 Date Apr. 17, 1995 Sec. 102(e) Date Apr. 17, 1995 PCT Filed Mar. 1, 1993 PCT Pub. No. WO93/16729 PCT Pub. Date Sep. 2, 1993Anti-human IgM antibody; in particular, an anti-human mu chain antibody can be employed for reducing patient levels of natural antibodies which are xenoreactive to eliminate or reduce the severity of xenograft rejection.